1. Home
  2. INM vs EAD Comparison

INM vs EAD Comparison

Compare INM & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • EAD
  • Stock Information
  • Founded
  • INM 1981
  • EAD 2003
  • Country
  • INM Canada
  • EAD United States
  • Employees
  • INM N/A
  • EAD N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • EAD Finance/Investors Services
  • Sector
  • INM Health Care
  • EAD Finance
  • Exchange
  • INM Nasdaq
  • EAD Nasdaq
  • Market Cap
  • INM 3.2M
  • EAD 406.6M
  • IPO Year
  • INM N/A
  • EAD N/A
  • Fundamental
  • Price
  • INM $2.75
  • EAD $7.04
  • Analyst Decision
  • INM
  • EAD
  • Analyst Count
  • INM 0
  • EAD 0
  • Target Price
  • INM N/A
  • EAD N/A
  • AVG Volume (30 Days)
  • INM 5.7M
  • EAD 178.9K
  • Earning Date
  • INM 05-12-2025
  • EAD 01-01-0001
  • Dividend Yield
  • INM N/A
  • EAD 8.91%
  • EPS Growth
  • INM N/A
  • EAD N/A
  • EPS
  • INM N/A
  • EAD N/A
  • Revenue
  • INM $4,920,990.00
  • EAD N/A
  • Revenue This Year
  • INM N/A
  • EAD N/A
  • Revenue Next Year
  • INM N/A
  • EAD N/A
  • P/E Ratio
  • INM N/A
  • EAD N/A
  • Revenue Growth
  • INM N/A
  • EAD N/A
  • 52 Week Low
  • INM $1.72
  • EAD $5.69
  • 52 Week High
  • INM $15.70
  • EAD $6.81
  • Technical
  • Relative Strength Index (RSI)
  • INM 46.31
  • EAD 68.99
  • Support Level
  • INM $2.66
  • EAD $7.00
  • Resistance Level
  • INM $2.97
  • EAD $7.14
  • Average True Range (ATR)
  • INM 0.37
  • EAD 0.06
  • MACD
  • INM -0.05
  • EAD 0.01
  • Stochastic Oscillator
  • INM 15.12
  • EAD 77.14

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About EAD Allspring Income Opportunities Fund

Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.

Share on Social Networks: